(Q42246515)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068739%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Use of collateral sensitivity networks to design drug cycling protocols that avoid resistance development (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068739%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068739%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Morten O A Sommer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068739%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

English

0 references

publication date

1 September 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068739%20AND%20SRC:MED&resulttype=core&format=json

Science Translational Medicine

23 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068739%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068739%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

204

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068739%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

204ra132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24068739%20AND%20SRC:MED&resulttype=core&format=json

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

23 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Outwitting evolution: fighting drug-resistant TB, malaria, and HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Scaling up interventions to achieve global tuberculosis control: progress and new developments

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Collateral sensitivity as a strategy against cancer multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Antibiotics for emerging pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Challenges of antibacterial discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Combination therapies for combating antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Conclusions: the future of antimicrobial therapy - Augmentin and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Antibiotic interactions that select against resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Antimicrobial stewardship programs (ASPs): the devil is in the details

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Appropriate use of antimicrobial agents: challenges and strategies for improvement

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Antibiotic cycling: more than it might seem?

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Antibiotic heterogeneity: from concept to practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Interplay in the selection of fluoroquinolone resistance and bacterial fitness

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Impaired fitness and transmission of macrolide-resistant Campylobacter jejuni in its natural host

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

The competitive cost of antibiotic resistance in Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Assessing the emergence of resistance: the absence of biological cost in vivo may compromise fosfomycin treatments for P. aeruginosa infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Antibiotic cycling or rotation: a systematic review of the evidence of efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Antibiotic rotation and development of gram-negative antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Determination of antibiotic hypersensitivity among 4,000 single-gene-knockout mutants of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Antibiotic sensitivity profiles determined with an Escherichia coli gene knockout collection: generating an antibiotic bar code

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Hospital-acquired infections due to gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Mutant selection window hypothesis updated.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Selection of resistance at lethal and non-lethal antibiotic concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Drugs, their targets and the nature and number of drug targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609

Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCITRANSLMED.3006609